Deficiency of corticotropin-releasing hormone type-2 receptor alters sleep responses to bacterial lipopolysaccharide in mice

Brain, Behavior, and Immunity

Volumn 25, Issue 8, 2011, Pages 1626-1636

  Jakubcakova, Vladimira ^a   Flachskamm, Cornelia ^a   Deussing, Jan M ^a,b   Kimura, Mayumi ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Acute phase responses (APRs); Corticotropin releasing hormone (CRH) receptor 2; Delta power; Host defense; Hypothalamus pituitary adrenocortical (HPA) axis activity; Knockout mice; Lipopolysaccharide (LPS); Sleep

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; GENOTYPE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; SLEEP WAKING CYCLE;

ANIMALS; CORTICOSTERONE; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYSOMNOGRAPHY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SLEEP; SLEEP STAGES; SLEEP, REM;

EID: 80053928915     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.06.008     Document Type: Article

References (72)

1. Agelaki S., Tsatsanis C., Gravanis A., Margioris A.N. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect. Immun. 2002, 70:6068-6074.
2. Baigent S.M. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 2001, 22:809-820.
3. Baker C., Richards L.J., Dayan C.M., Jessop D.S. Corticotropin-releasing hormone immunoreactivity in human T and B cells and macrophages: colocalization with arginine vasopressin. J. Neuroendocrinol. 2003, 15:1070-1074.
4. Bale T.L., Vale W.W. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci. 2003, 23:5295-5301.
5. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 2000, 24:410-414.
6. Baracchi F., Opp M.R. Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1. Brain Behav. Immun. 2008, 22:982-993.
7. Bomar J.M., Opp M.R. Intracerebroventricular administration of human urocortin 2 increases wakefulness in rat. Sleep 2005, 28:13.
8. Breder C.D., Hazuka C., Ghayur T., Klug C., Huginin M., Yasuda K., Teng M., Saper C.B. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl Acad. Sci. USA 1994, 91:11393-11397.
9. Buckingham J.C., Solito E., John C., Tierney T., Taylor A., Flower R., Christian H., Morris J. Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system. Cell Biochem. Funct. 2003, 21:217-221.
10. Chang F.C., Opp M.R. Corticotropin-releasing hormone (CRH) as a regulator of waking. Neurosci. Biobehav. Rev. 2001, 25:445-453.
11. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., Murray S.E., Hill J.K., Pantely G.A., Hohimer A.R., Hatton D.C., Phillips T.J., Finn D.A., Low M.J., Rittenberg M.B., Stenzel P., Stenzel-Poore M.P. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:403-409.
12. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
13. Datta S.C., Opp M.R. Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology. J. Neurosci. Methods 2008, 175:119-124.
14. Deussing J.M., Breu J., Kuhne C., Kallnik M., Bunck M., Glasl L., Yen Y.C., Schmidt M.V., Zurmuhlen R., Vogl A.M., Gailus-Durner V., Fuchs H., Holter S.M., Wotjak C.T., Landgraf R., de Angelis M.H., Holsboer F., Wurst W. Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J. Neurosci. 2010, 30:9103-9116.
15. Ding M., Toth L.A. MRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation. Physiol. Genomics 2006, 24:225-234.
16. Ehlers C.L., Kupfer D.J., Buysse D.J., Cluss P.A., Miewald J.M., Bisson E.F., Grochocinski V.J. The Pittsburgh study of normal sleep in young adults: focus on the relationship between waking and sleeping EEG spectral patterns. Electroencephalogr. Clin. Neurophysiol. 1998, 106:199-205.
17. Elmquist J.K., Saper C.B. Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. J. Comp. Neurol. 1996, 374:315-331.
18. Emeric-Sauval E. Corticotropin-releasing factor (CRF) - a review. Psychoneuroendocrinology 1986, 11:277-294.
19. Fenzl T., Romanowski C.P., Flachskamm C., Deussing J.M., Kimura M. Wake-promoting effects of orexin: its independent actions against the background of an impaired corticotropine-releasing hormone receptor system. Behav. Brain Res. 2011, 222:43-50.
20. Franken P., Malafosse A., Tafti M. Genetic variation in EEG activity during sleep in inbred mice. Am. J. Physiol. 1998, 275:R1127-1137.
21. Grammatopoulos D.K., Chrousos G.P. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol. Metab. 2002, 13:436-444.
22. Greisman S.E., Young E.J., Workman J.B., Ollodart R.M., Hornick R.B. Mechanisms of endotoxin tolerance. The role of the spleen. J. Clin. Invest. 1975, 56:1597-1607.
23. Harbuz M.S., Chover-Gonzalez A., Gibert-Rahola J., Jessop D.S. Protective effect of prior acute immune challenge, but not footshock, on inflammation in the rat. Brain Behav. Immun. 2002, 16:439-449.
24. Held K., Kunzel H., Ising M., Schmid D.A., Zobel A., Murck H., Holsboer F., Steiger A. Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. J. Psychiatr. Res. 2004, 38:129-136.
25. Hu W.P., Li J.D., Colwell C.S., Zhou Q.Y. Decreased REM sleep and altered circadian sleep regulation in mice lacking vasoactive intestinal polypeptide. Sleep 2011, 34:49-56.
26. Imeri L., Bianchi S., Opp M.R. Inhibition of caspase-1 in rat brain reduces spontaneous nonrapid eye movement sleep and nonrapid eye movement sleep enhancement induced by lipopolysaccharide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R197-R204.
27. Jhaveri K.A., Ramkumar V., Trammell R.A., Toth L.A. Spontaneous, homeostatic, and inflammation-induced sleep in NF-kappaB p50 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1516-R1526.
28. Kageyama K., Li C., Vale W.W. Corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in rat pituitary: localization and regulation by immune challenge, restraint stress, and glucocorticoids. Endocrinology 2003, 144:1524-1532.
29. Kakucska I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 1993, 133:815-821.
30. Kimura M., Muller-Preuss P., Lu A., Wiesner E., Flachskamm C., Wurst W., Holsboer F., Deussing J.M. Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol. Psychiatry 2010, 15:154-165.
31. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:415-419.
32. Koons A., Crandall M., An G.C., Shapiro M.B., Kramer S., West M.A. Even ephemeral endotoxin exposure establishes endotoxin tolerance. J. Trauma 2008, 64:938-942.
33. Krueger J.M., Kubillus S., Shoham S., Davenne D. Enhancement of slow-wave sleep by endotoxin and lipid A. Am. J. Physiol. 1986, 251:R591-R597.
34. Krueger J.M., Majde J.A., Obal F. Sleep in host defense. Brain Behav. Immun. 2003, 17(Suppl 1):S41-S47.
35. Lancel M., Cronlein J., Muller-Preuss P., Holsboer F. Lipopolysaccharide increases EEG delta activity within non-REM sleep and disrupts sleep continuity in rats. Am. J. Physiol. 1995, 268:R1310-R1318.
36. Louis R.P., Lee J., Stephenson R. Design and validation of a computer-based sleep-scoring algorithm. J. Neurosci. Methods 2004, 133:71-80.
37. Majde J.A., Krueger J.M. Links between the innate immune system and sleep. J. Allergy Clin. Immunol. 2005, 116:1188-1198.
38. Makino S., Takemura T., Asaba K., Nishiyama M., Takao T., Hashimoto K. Differential regulation of type-1 and type-2alpha corticotropin-releasing hormone receptor mRNA in the hypothalamic paraventricular nucleus of the rat. Brain Res. Mol. Brain Res. 1997, 47:170-176.
39. Meltzer J.C., MacNeil B.J., Sanders V., Pylypas S., Jansen A.H., Greenberg A.H., Nance D.M. Contribution of the adrenal glands and splenic nerve to LPS-induced splenic cytokine production in the rat. Brain Behav. Immun. 2003, 17:482-497.
40. Morrow J.D., Opp M.R. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav. Immun. 2005, 19:28-39.
41. Mullington J., Korth C., Hermann D.M., Orth A., Galanos C., Holsboer F., Pollmacher T. Dose-dependent effects of endotoxin on human sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R947-R955.
42. Olivadoti M.D., Opp M.R. Effects of i.c.v. administration of interleukin-1 on sleep and body temperature of interleukin-6-deficient mice. Neuroscience 2008, 153:338-348.
43. Olivadoti M.D., Weinberg J.B., Toth L.A., Opp M.R. Sleep and fatigue in mice infected with murine gammaherpesvirus 68. Brain Behav. Immun. 2011, 25:696-705.
44. Opp M.R. Rat strain differences suggest a role for corticotropin-releasing hormone in modulating sleep. Physiol. Behav. 1998, 63:67-74.
45. Opp M.R. Cytokines and sleep. Sleep Med. Rev. 2005, 9:355-364.
46. Opp M.R. Sleeping to fuel the immune system: mammalian sleep and resistance to parasites. BMC Evol. Biol. 2009, 9:8.
47. Opp M.R., Toth L.A. Somnogenic and pyrogenic effects of interleukin-1beta and lipopolysaccharide in intact and vagotomized rats. Life Sci. 1998, 62:923-936.
48. Perlstein R.S., Whitnall M.H., Abrams J.S., Mougey E.H., Neta R. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993, 132:946-952.
49. Preston B.T., Capellini I., McNamara P., Barton R.A., Nunn C.L. Parasite resistance and the adaptive significance of sleep. BMC Evol. Biol. 2009, 9:7.
50. Quan N., Whiteside M., Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res. 1998, 802:189-197.
51. Rearte B., Landoni V., Laborde E., Fernandez G., Isturiz M. Differential effects of glucocorticoids in the establishment and maintenance of endotoxin tolerance. Clin. Exp. Immunol. 2009, 159:208-216.
52. Reul J.M., Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2002, 2:23-33.
53. Rivest S., Laflamme N., Nappi R.E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosci. 1995, 15:2680-2695.
54. Rivier C., Vale W., Brown M. In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release. Endocrinology 1989, 125:3096-3102.
55. Rivier C.L., Grigoriadis D.E., Rivier J.E. Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 2003, 144:2396-2403.
56. Romanowski C.P., Fenzl T., Flachskamm C., Deussing J.M., Kimura M. CRH-R2 evidently is not involved in effects of CRH on sleep suppression. J. Sleep Res. 2008, 17:201-202.
57. Romanowski C.P., Fenzl T., Flachskamm C., Wurst W., Holsboer F., Deussing J.M., Kimura M. Central deficiency of corticotropin-releasing hormone receptor type 1 (CRH-R1) abolishes effects of CRH on NREM but not on REM sleep in mice. Sleep 2010, 33:427-436.
58. Sanford L.D., Yang L., Wellman L.L., Dong E., Tang X. Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness. Brain Res. 2008, 1190:94-104.
59. Schiffelholz T., Lancel M. Sleep changes induced by lipopolysaccharide in the rat are influenced by age. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R398-R403.
60. Shoham S., Davenne D., Cady A.B., Dinarello C.A., Krueger J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am. J. Physiol. 1987, 253:R142-R149.
61. Toth L.A., Krueger J.M. Effects of microbial challenge on sleep in rabbits. FASEB J. 1989, 3:2062-2066.
62. Toth L.A., Opp M.R. Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R1806-R1814.
63. Toth L.A., Williams R.W. A quantitative genetic analysis of slow-wave sleep in influenza-infected CXB recombinant inbred mice. Behav. Genet. 1999, 29:339-348.
64. Toth L.A., Rehg J.E., Webster R.G. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J. Neuroimmunol. 1995, 58:89-99.
65. Uchida M., Suzuki M., Shimizu K. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats. Biol. Pharm. Bull. 2007, 30:1895-1897.
66. Vallieres L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J. Neurochem. 1997, 69:1668-1683.
67. Van Pett K., Viau V., Bittencourt J.C., Chan R.K.W., Li H.-Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
68. Werling D., Piercy J., Coffey T.J. Expression of TOLL-like receptors (TLR) by bovine antigen-presenting cells-potential role in pathogen discrimination?. Vet. Immunol. Immunopathol. 2006, 112:2-11.
69. Werling D., Jann O.C., Offord V., Glass E.J., Coffey T.J. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 2009, 30:124-130.
70. West M.A., Clair L., Kraatz J., Rodriguez J.L. Endotoxin tolerance from lipopolysaccharide pretreatment induces nuclear factor-kappaB alterations not present in C3H/HeJ mice. J. Trauma 2000, 49:298-305.
71. Winsky-Sommerer R., Vyazovskiy V.V., Homanics G.E., Tobler I. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABAAδ-subunit-containing receptors. Eur. J. NeuroSci. 2007, 25:1893-1899.
72. Zager A., Andersen M.L., Lima M.M., Reksidler A.B., Machado R.B., Tufik S. Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice. Eur. Neuropsychopharmacol. 2009, 19:589-602.